Tag Archives: R&D
By Julian Upton | Published: February 26, 2014
Bioscience research in China is set to overtake the United States within the next five to ten years, according to data from search engine CiteAb.
By Guest Blogger | Published: February 24, 2014
Risk-Based Monitoring: From the Road Less Traveled to Productivity Superhighway By: Mukhtar Ahmed, global vice president, life sciences strategy, Oracle Health Sciences The latest news on the growing cost of conducting clinical trials is becoming a major concern for company sponsors and trial co-operative groups. Clinical trials cost 60% more today than they did just […]
By Guest Blogger | Published: February 18, 2014
America’s biopharmaceutical research companies are currently developing 180 new medicines to help the nearly 400 million people who have diabetes worldwide. These medicines in development, all either in clinical trials or under review by FDA, include 30 for type 1 diabetes, 100 for type 2, and 52 for diabetes-related conditions, according to a new report […]
By Guest Blogger | Published: February 12, 2014
By Moe Alsumidaie. The clinical trial technological landscape continues to morph, as we are starting to see the emergence of novel technologies and techniques to enhance clinical trial strategies and productivity. Study site/enrollment optimization, patient engagement, and big data were hot topics at this year’s SCOPE Summit in Miami, FL, last week.
By Jill Wechsler | Published: February 7, 2014
The Patient-Centered Outcomes Research Institute (PCORI) is launching new programs that are expected to encourage more analysis of the effectiveness of specific drugs and medical products, while also building infrastructure that could support clinical research on biopharmaceutical products. Since it was established by the 2010 health reform legislation, PCORI has devoted much of its resources […]